Xenograft trials/mouse numbers
| Trial . | Treatment groups* . | |||||
|---|---|---|---|---|---|---|
| No treatment . | HB22.7 . | RIT . | −24 . | @RIT . | +24 . | |
| 081500 | 5 | 4 | 9 | 5 | 5 | 5 |
| 101600 | 5 | 6 | 5 | 5 | 3 | 5 |
| 011601 | — | 5 | 4 | — | 9 | 7 |
| 032701 | — | 5 | 2 | — | 3 | 12 |
| 052401 | 3 | — | 3 | — | — | — |
| 060401 | 5 | 5 | — | — | — | — |
| 071701 | 7 | 5 | — | — | — | 4 |
| 092101 | 4 | — | — | — | — | — |
| 102401 | 13 | — | — | — | — | — |
| Total | 42 | 30 | 23 | 10 | 20 | 33 |
| Trial . | Treatment groups* . | |||||
|---|---|---|---|---|---|---|
| No treatment . | HB22.7 . | RIT . | −24 . | @RIT . | +24 . | |
| 081500 | 5 | 4 | 9 | 5 | 5 | 5 |
| 101600 | 5 | 6 | 5 | 5 | 3 | 5 |
| 011601 | — | 5 | 4 | — | 9 | 7 |
| 032701 | — | 5 | 2 | — | 3 | 12 |
| 052401 | 3 | — | 3 | — | — | — |
| 060401 | 5 | 5 | — | — | — | — |
| 071701 | 7 | 5 | — | — | — | 4 |
| 092101 | 4 | — | — | — | — | — |
| 102401 | 13 | — | — | — | — | — |
| Total | 42 | 30 | 23 | 10 | 20 | 33 |
Treatment groups consisted of HB22.7 alone; RIT alone; and HB22.7 administered 24 h prior to (−24), simultaneous with (@RIT), or 24 h after (+24) administration of RIT.